Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

Published:2000-09 Issue:2 Volume:109 Page:121-131
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Graesser Donnasue,Mahooti Sepi,Madri Joseph A

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference29 articles.

1. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma;Baron;J. Exp. Med.,1993

2. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta;Calabresi;Neurology,1997

3. Reversal of experimental autoimmune encephalomyelitis with a hydroxymate inhibitor of matrix metalloproteases;Gijbels;J. Clin. Invest.,1994

4. The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis;Graesser;Lab. Invest.,1998

5. T cells with two functional antigen-specific receptors;Hardardottir;Proc. Natl. Acad. Sci. USA,1995

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis;Frontiers in Immunology;2023-04-18

2. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology;Pharmacological Reviews;2022-07

3. Application of a triple‐helical peptide inhibitor of MMP ‐2/ MMP ‐9 to examine T‐cell activation in experimental autoimmune encephalomyelitis;Peptide Science;2022-03-07

4. Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients;Scientific Reports;2019-01-22

5. Interplay between metalloproteinases and cell signalling in blood brain barrier integrity;HISTOL HISTOPATHOL;2018